Similar Posts
FDA approves new Alzheimer’s drug donanemab in the US
ByJDCteamThe US Food and Drug Administration (FDA) has approved donanemab, a drug for Alzheimer’s disease, for people in the US with confirmed amyloid positivity and a diagnosis of mild cognitive impairment (MCI) or early-stage Alzheimer’s disease. Donanemab is an antibody-based treatment intended to remove amyloid. It is given as an infusion into a person’s arm…
Spotlight on local priorities
ByJDCteamRegistration is now open for the Alzheimer’s Society Annual Conference, which returns for 2023 during Dementia Action Week. The conference will put a spotlight on making dementia a priority locally, bringing together local leaders in dementia from across the UK to share best practice and challenges, and progress towards aims and ambitions in diagnosis and…
TIDE’s work continues with an expanded Carer Development Programme
ByJDCteamAfter a threat to their survival, TIDE (Together in Dementia Everyday) have announced that they’ve secured funding to continue their work supporting family carers of people with dementia until at least September 2024. TIDE are expanding their Carer Development Programme, a co-produced course of online events that are designed to help unpaid carers by giving…
Blood test diagnosis
ByJDCteamA new blood test developed at Pittsburgh University may hold the key to diagnosing Alzheimer’s disease relatively inexpensively. Results published in the journal Brain show that the test reliably detects a biomarker called “brain-derived tau”, using an antibody that selectively binds this protein found specifically in the blood of people with Alzheimer’s. “At present, diagnosing…
White paper published on the responsible use of Generative AI in adult social care
ByJDCteamFollowing the AI in Social Care Summit that was held in March 2025, a white paper summarising the Summit’s findings has been published entitled, ‘The responsible use of Generative AI in adult social care: A value led approach.’ The white paper, co-authored by the Oxford Institute for Ethics in AI, the Digital Care Hub and…
Right to end-of-life care
ByJDCteamDying people’s right to health care has been made explicit in law for the first time under new government plans for England. Alongside the government announcement, end of life charity Marie Curie released figures showing that around 215,000 people miss out on end-of-life care every year. Baroness Illora Finlay described the change in the law,…